You have 9 free searches left this month | for more free features.

Trebananib

Showing 1 - 25 of 29

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +15 more
  • trebananib
  • +3 more
  • Buffalo, New York
  • +1 more
Sep 8, 2022

Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

Recruiting
  • Breast Neoplasms
  • +10 more
  • Standard Therapy
  • +32 more
  • Birmingham, Alabama
  • +35 more
Nov 17, 2022

Advanced Renal Cell Carcinoma Trial (Sunitinib, Trebananib)

Completed
  • Advanced Renal Cell Carcinoma
  • (no location specified)
Jun 10, 2020

Prostatic Tumors, Prostate Cancer, Tumor, Prostate Trial in Bethesda, Philadelphia (AMG 386, Abiraterone, Prednisone)

Completed
  • Prostatic Neoplasms
  • +3 more
  • AMG 386
  • +2 more
  • Bethesda, Maryland
  • +1 more
Feb 11, 2019

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial (AMG 386, Paclitaxel, AMG 386 Placebo)

Completed
  • Ovarian Cancer
  • +2 more
  • AMG 386
  • +2 more
  • (no location specified)
Dec 16, 2019

Breast Cancer, Breast Tumors, Breast Tumors Trial in Belgium, France, United States (AMG 386 30 mg/kg, Paclitaxel and

Completed
  • Breast Cancer
  • +9 more
  • AMG 386 30 mg/kg, Paclitaxel and Trastuzumab
  • +3 more
  • Tucson, Arizona
  • +22 more
Apr 2, 2019

Glioblastoma Multiforme Trial in United States (Amgen 386, Bevacizumab)

Completed
  • Glioblastoma Multiforme
  • Los Angeles, California
  • +5 more
Jun 4, 2017

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer Trial in Worldwide (AMG386 plus PLD, Placebo plus PLD)

Terminated
  • Fallopian Tube Cancer
  • +2 more
  • AMG386 plus PLD
  • Placebo plus PLD
  • Los Angeles, California
  • +105 more
Nov 27, 2017

CNS Tumor, Solid Tumor Trial in Canada, United States (procedure, other, biological)

Completed
  • Central Nervous System Neoplasm
  • Solid Neoplasm
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • +3 more
  • Birmingham, Alabama
  • +21 more
Sep 30, 2016

Advanced Solid Tumors, Kidney Disease, Renal Impairment Trial in United States (AMG 386 + Paclitaxel, AMG 386)

Completed
  • Advanced Solid Tumors
  • +2 more
  • AMG 386 + Paclitaxel
  • AMG 386
  • Atlanta, Georgia
  • +3 more
Nov 1, 2017

Tumors, Advanced Solid Trial (Trebananib 3 mg/kg, Trebananib 10 mg/kg, Trebananib 30 mg/kg)

Completed
  • Neoplasms, Advanced Solid
  • Trebananib 3 mg/kg
  • +2 more
  • (no location specified)
Aug 19, 2015

Advanced Solid Tumors Trial (Sorafenib, AMG 706, AMG 386)

Completed
  • Advanced Solid Tumors
  • (no location specified)
Feb 7, 2017

Adult Solid Tumor, Lung Carcinoid Tumor, Recurrent Digestive System Neuroendocrine Tumor G1 Trial in Vancouver, Hamilton,

Completed
  • Adult Solid Neoplasm
  • +10 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Vancouver, British Columbia, Canada
  • +2 more
Oct 5, 2015

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer Trial in Worldwide (AMG 386, AMG 386 Placebo, Paclitaxel)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • AMG 386
  • +2 more
  • Phoenix, Arizona
  • +224 more
Dec 14, 2016

Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer Trial in Worldwide (AMG 386, Paclitaxel, AMG 386 Placebo)

Terminated
  • Fallopian Tube Cancer
  • +2 more
  • AMG 386
  • +3 more
  • Birmingham, Alabama
  • +309 more
Feb 22, 2017

Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States (Laboratory

Completed
  • Adult Angiosarcoma
  • +3 more
  • Laboratory Biomarker Analysis
  • Trebananib
  • Lewes, Delaware
  • +69 more
Sep 28, 2015

Non Small Cell Lung Cancer Trial in Worldwide (AMG 386, AMG 386 Placebo, Pemetrexed)

Completed
  • Non Small Cell Lung Cancer
  • AMG 386
  • +3 more
  • Fayetteville, Arkansas
  • +34 more
May 18, 2016

Advanced Renal Cell Carcinoma Trial (AMG 386, Sorafenib, AMG 386 IV)

Completed
  • Advanced Renal Cell Carcinoma
  • AMG 386
  • +2 more
  • (no location specified)
Feb 23, 2016

Advanced Hepatocellular Carcinoma, Inoperable Hepatocellular Carcinoma Trial (AMG 386, Sorafenib)

Completed
  • Advanced Hepatocellular Carcinoma
  • Inoperable Hepatocellular Carcinoma
  • (no location specified)
Mar 7, 2016

Carcinoma, Fallopian Tube Cancer, Ovarian Cancer Trial in Australia, Belgium, Spain (AMG 386, paclitaxel and carboplatin)

Completed
  • Carcinoma
  • +3 more
  • AMG 386, paclitaxel and carboplatin
  • Footscray, Victoria, Australia
  • +7 more
Oct 13, 2015

Cancer, Carcinoma, Colon Cancer Trial (AMG 386, AMG 386 Placebo, FOLFIRI)

Completed
  • Cancer
  • +9 more
  • AMG 386
  • +2 more
  • (no location specified)
Aug 14, 2015

Cancer, Carcinoma, Fallopian Tube Cancer Trial in Australia, Belgium, United States (A1: AMG 386 10 mg/kg + Liposomal

Completed
  • Cancer
  • +8 more
  • A1: AMG 386 10 mg/kg + Liposomal doxorubicin
  • +3 more
  • Tucson, Arizona
  • +15 more
Sep 25, 2015

Urothelial Carcinoma Trial (AMG 386, Docetaxel)

Withdrawn
  • Urothelial Carcinoma
  • (no location specified)
Apr 25, 2014

Locally Recurrent and Metastatic Breast Cancer Trial in Worldwide (AMG 386 Placebo, AMG 386, Bevacizumab)

Completed
  • Locally Recurrent and Metastatic Breast Cancer
  • AMG 386 Placebo
  • +3 more
  • Litchfield Park, Arizona
  • +76 more
Oct 7, 2015